Therapeutic targeting of lipid synthesis metabolism for selective elimination of cancer stem cells

Arch Pharm Res. 2019 Jan;42(1):25-39. doi: 10.1007/s12272-018-1098-z. Epub 2018 Dec 8.

Abstract

Cancer stem cells (CSCs) are believed to have an essential role in tumor resistance and metastasis; however, no therapeutic strategy for the selective elimination of CSCs has been established. Recently, several studies have shown that the metabolic regulation for ATP synthesis and biological building block generation in CSCs are different from that in bulk cancer cells and rather similar to that in normal tissue stem cells. To take advantage of this difference for CSC elimination therapy, many studies have tested the effect of blocking these metabolism. Two specific processes for lipid biosynthesis, i.e., fatty acid unsaturation and cholesterol biosynthesis, have been shown to be very effective and selective for CSC targets. In this review, lipid metabolism specific to CSCs are summarized. In addition, how monounsaturated fatty acid and cholesterol synthesis may contribute to CSC maintenance are discussed. Specifically, the molecular mechanism required for lipid synthesis and essential for stem cell biology is highlighted. The limit and preview of the lipid metabolism targeting for CSCs are also discussed.

Keywords: Cancer stem cells; Cholesterol; Monounsaturated fatty acid; Notch; WNT.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Drug Delivery Systems / methods*
  • Humans
  • Lipid Metabolism / drug effects*
  • Lipid Metabolism / physiology
  • Lipogenesis / drug effects
  • Lipogenesis / physiology
  • Neoplastic Stem Cells / drug effects*
  • Neoplastic Stem Cells / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology

Substances

  • Antineoplastic Agents